Carly Hicks

Carly's expertise spans a wide array of corporate dealings, notably in mergers, restructurings, investments, and day-to-day business agreements. Since her initial steps as a summer intern in 2018, followed by her full-fledged involvement post her articles period at Blakes in the 2019-2020 cycle, she's been pivotal in numerous high-stake projects.

Her work includes advising Koru LP, an innovation lab birthed by the Ontario Teachers' Pension Plan, on diverse initiatives, aiding a notable private equity entity in streamlining dental and orthodontic clinics nationwide, and steering various pension schemes through their ventures in real estate and investment funds. Notably, she played a crucial role in Eli Lilly's pivotal investment in Entos Pharmaceuticals, marking a significant step towards advancing genetic medicine technologies.

Moreover, Carly's contributions were instrumental in Schlesinger Group's acquisition of Methodify and AskingCanadians, underpinning Gauge Capital's portfolio expansion. Her involvement didn't stop there; she also facilitated L Catterton's acquisition of Beauty Industry Group, underscoring her versatility across sectors. Sagard Holdings' strategic investment in Grayhawk Investment Strategies and a private equity firm's acquisition of a gaming supplier further exemplify her breadth of experience.

Her foundational education, a JD from the University of Toronto Faculty of Law and a BBA from Wilfrid Laurier University, laid the groundwork for her flourishing career. Carly's journey is not just a testament to her legal acumen but also her dynamic ability to navigate complex commercial landscapes, making her an indispensable asset in the realms of corporate and commercial law, cross-border transactions, and private M&A in the private equity sector.